Remove 2018 Remove Biosimilars Remove Insurance Coverage and Processing
article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

The increase in ENBREL sales for 2019 vs 2018 was primarily driven by favorable changes to estimated sales deductions and an increase in net selling price, partially offset by lower unit demand. Some of its approved biosimilars are mentioned below along with the regulatory bodies they are approved by*. Enbrel Prescribing Information 3.